December 21, 2020 — U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott's HeartMate 3left ventricular assist device (LVAD) to be used in pediatric patients with advanced refractory left ventricular heart failure.
New for 2021, Heart Rhythm Society annual meeting now allows you to choose your experience — virtual or in-person. Heart Rhythm 2021 will kick off virtually on June 30, then in-person from July 28-31 in Boston, MA.
New for 2021, Heart Rhythm Society annual meeting now allows you to choose your experience — virtual or in-person. Heart Rhythm 2021 will kick off virtually on June 30, then in-person from July 28-31 in Boston, MA.
December 16, 2020 — AI Medic Inc. announced that it has obtained official product certification from the NIDS (National Institute of Medical Device Safety Information) for its own medical video analysis software called "AutoSEG".
December 16, 2020 — Efemoral Medical announced the first-in-human (FIH) use of the its Efemoral bioresorbable vascular scaffold system (EVSS) with FlexStep Technology in the EFEMORAL I FIH clinical study. The bioresorbable stent is designed to address a broad range of patients with peripheral arteri
December 16, 2020 — Corindus, A Siemens Healthineers company and a leading developer of vascular robotics, began its global launch of a new set of automated robotic movements in the technIQ Series designed for the CorPath GRX System. The company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software automation that provides predictable and consistent movements to aid in advanced device manipulation during complex coronary and peripheral procedures.
